Same Indication

Liraglutide vs Upadacitinib

Liraglutide vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Liraglutide and Upadacitinib.

Mechanism of Action

Liraglutide: GLP-1 receptor agonist enhancing insulin secretion.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Liraglutide β€” 13 hours; Upadacitinib β€” 9-14 hours.

Chemical Properties

Molecular Formula: Upadacitinib β€” C17H19F3N6O.

Molecular Weight: Upadacitinib β€” 380.3700 g/mol.

Type: Liraglutide β€” Protein; Upadacitinib β€” Small molecule.